A Double-Blind, Randomized, Placebo-Controlled, Dose-Ranging Study To Evaluate The Efficacy And Safety Of PF-00547659 In Subjects With Crohn's Disease (OPERA)
Phase of Trial: Phase II
Latest Information Update: 05 Oct 2017
At a glance
- Drugs SHP 647 (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- Acronyms OPERA
- Sponsors Pfizer
- 05 Oct 2017 Results published in the Gut
- 04 Jan 2016 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov record.
- 19 May 2015 Results presented at the Digestive Disease Week 2015.